Researchers target physiological factors that lead to asthma attack

A new study that identifies ways to reduce the factors that lead to an asthma attack gives hope to asthma sufferers. A UCSF researcher and his colleagues believe they have found a way to help asthma sufferers by impeding the two most significant biological responses that lead to an asthma attack.

Asthma, a that causes shortness of breath, coughing and chest discomfort, results from changes in the airways that lead to the lungs. It affects 18.7 million adults and 7.0 million children in the US, according to the .

In a paper published Monday in the (PNAS), researchers from UCSF, Johns Hopkins University and Duke University demonstrate that a specific calcium-activated holds valuable clues to reducing two biological processes that contribute to the severity of asthma. These channels regulate airway secretions and contraction, the two major factors that lead to an .

"Maybe if we could inhibit both of these processes by blocking this one channel, then we could affect the two symptoms of asthma," said senior author Jason Rock, PhD, assistant professor at the UCSF Department of Anatomy.

Normally humans have few mucus-producing cells but asthma sufferers have an elevated number of these cells in the lining of the tubes that lead to the lungs. Asthmatics also have an abnormal amount of smooth muscle surrounding the airway tubes. Even the slightest stimulus can cause these to contract.

"The overabundance of mucus plugging the airways combined with hyper-contractility of the smooth muscle – when the tubes get really small – make it difficult to move air in or out," Rock said. "A lot of people equate that with breathing through a straw."

Rock and his colleagues focused on a calcium-activated chloride channel called TMEM16A. This channel secretes in response to rises in intracellular calcium. It regulates a significant number of biological processes such as neuron firing, gastrointestinal activity and the secretion of sweat and tears.

The researchers wanted to prove that the channel was present in asthma. They studied human lung samples and looked for the mRNA (messenger RNA which carries information from the DNA to the sites of protein synthesis), and compared protein levels in asthmatic and non-asthmatic patients.

"We found that the level of this channel was increased in the mucus producing cells of asthmatics compared to non-asthmatics," Rock said. "And we also validated this in several models of asthma, including mouse models. That was step one."

Step two consisted of a screen to identify chemicals that inhibit the activity of TMEM16A. The authors identified three chemicals that inhibit the channel.

"We tested the ability of these chemicals to inhibit TMEM16A and other channels, and we found that they specifically block TMEM16A," Rock said. "It is great that we came across these molecules that were unknown previously since we can now try to get into clinical trials to benefit patients."

Then, the authors simulated asthma in a dish and blocked the channel to observe whether it affected mucus production. "Mucus produced by these cells wasn't secreted as efficiently," Rock said. "We also studied airway smooth muscles of human patients who had given their organs to science, and we could see that blocking TMEM16A inhibited their contraction response as well."

Rock is in the pre-clinical phase to test the safety and effectiveness of the blockers in animal studies. If that goes well, Phase One of clinical trials can begin.

"At present, I am optimistic," Rock said. "This could be a major advance to help sufferers."

Related Stories

Recommended for you

Ontario has one of the highest rates of IBD in the world

Aug 28, 2014

One in every 200 Ontarians has been diagnosed with inflammatory bowel disease (IBD), with the number of people living with the disease increasing by 64 per cent between 1999 and 2008, according to a study by researchers at ...

New drug promises relief for inflammatory pain

Aug 27, 2014

Pain from inflammation sidelines thousands of Americans each year. Many face a tough choice: deal with the pain, take a potentially addictive opioid or use a nonsteroidal anti-inflammatory drug that may increase risk for ...

Overweight causes hazardous inflammations

Aug 25, 2014

Researchers have found a possible molecular explanation for why overweight is harmful. This new knowledge may provide new drugs for heart attack, stroke, cancer and chronic intestinal inflammation.

Asthma outcomes worse in older women

Aug 21, 2014

(HealthDay)—Older women face increased challenges in managing their asthma, according to a review published in the August issue of the Annals of Allergy, Asthma & Immunology.

User comments